COMP <GO>
CTSO vs GUTS // EV/EBITDA & P/E VALUATION
Cytosorbents Corporation (NASDAQ) VS. Fractyl Health Inc. (NASDAQ) • 15-METRIC TALLY: CTSO 3
— GUTS 0
■ METRIC PARITY
LAST: $4.40 (-16.03%) • MKT CAP: $13.9M
valuation
—
LAST: $0.99 (+11.40%) • MKT CAP: $13.2M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CTSO VS. GUTS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CTSO | GUTS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 71.50% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -39.80% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -22.10% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 2/9 | +1.00 | CTSO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.9 | 17.0 | +30.88 | CTSO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $13.9M | $13.2M | $712.6K | CTSO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CTSO REV | GUTS REV | CTSO GROSS % | GUTS GROSS % | CTSO FCF | GUTS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $37.1M | $0 | 71.5% | — | -$12.5M | -$90.9M |
| FY 2024 | $35.6M | $93.0K | 69.9% | 46.2% | -$14.7M | -$67.3M |
| FY 2023 | $0 | $0 | — | — | -$21.7M | -$42.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CTSO // BETA —
GUTS // BETA —